Summary: In a double-blind randomised trial in type 2 diabetes with painful peripheral neuropathy, 16 weeks of nanocurcumin did not improve pain, neuropathy scores, or metabolic and cardiovascular measures compared with placebo, though it was well tolerated.
PICO Summary
| Element | Detail |
|---|---|
| Population | 97 randomised patients with type 2 diabetes and diabetic peripheral neuropathy (86 completed); Tehran, Iran. |
| Intervention | Nanocurcumin 40 mg twice daily for 16 weeks (n=41 completers). |
| Comparison | Placebo (n=45 completers). |
| Outcome | No significant difference in pain (Numerical Rating Scale, p=0.787), Neuropathy Disability Score (p=0.576), or Michigan Neuropathy Screening exam (p=0.405). No change in metabolic or cardiovascular parameters; well tolerated with no major adverse events. |
Nanocurcumin for diabetic nerve pain
RCT · type 2 diabetes · 16 weeks
Over 16 weeks nanocurcumin gave no better pain relief than placebo (NRS fell 6.3 to 5.2 with drug vs 5.8 to 5.0 with placebo, p=0.787) and did not improve neuropathy scores or metabolic measures. It was safe and well tolerated.
Expert Commentary
This is a clean negative trial and a valuable one, because diabetic peripheral neuropathy is common, hard to treat, and a magnet for supplement marketing. Curcumin’s anti-inflammatory and antioxidant properties make it biologically plausible, and animal studies were encouraging, but in actual patients a reasonably sized, blinded, placebo-controlled trial of a bioavailability-enhanced nanoformulation found nothing: no effect on pain, on validated neuropathy scores, or on metabolic and cardiovascular measures. The p-values are not borderline, they are clearly null, which makes the result hard to dismiss as underpowering alone. The reassuring side is that it was safe and well tolerated. Honest caveats: a single agent, dose, and 16-week window cannot exclude benefit under every condition, but the burden now sits with proponents to show it. Can I use this with my patients? Yes, directly. When a patient with diabetic nerve pain asks whether curcumin or turmeric capsules will help, I can give an evidence-based answer that this trial showed no benefit, spare them the cost, and redirect to what does help, glycaemic optimisation, B12 assessment, and proven neuropathic agents such as duloxetine, pregabalin, or gabapentin. Negative trials like this protect patients from false hope.
References
Mansour A, Rahimi HR, Gerami H, et al. The effectiveness and safety of nanocurcumin supplementation for diabetic peripheral neuropathy in patients with type 2 diabetes: a randomized double-blind clinical trial. Nutr J. 2025;24(1):115. doi:10.1186/s12937-025-01184-8